Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Biochip-images

Financiado

A Breast Cancer Biomarker Point of CarePOCDiagnostic Platform Integrating Dual F...

A Breast Cancer Biomarker Point of CarePOCDiagnostic Platform Integrating Dual Functionalized Nanoparticle for Magnetic Gradient Ranking and Electrochemical Sensing Breast cancer is the most common neoplasm in women and the second leading cause of cancer-related mortality in females worldwide, with 25.1% of incidence and 14.7% of mortality across all cancers. A convenient blood-based tumor ma... ver más

31/05/2022

NUID UCD

185K€

Presupuesto del proyecto: 185K€

Líder del proyecto

UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-05-31

MSCA-IF-2018: Individual Fellowships

I+D

Cerrada hace 6 años

0% 100%

2 Participantes

NUID UCD

184.59K€ | Lider

SCHMIDT-CLEMENS SPAIN

151.46K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EIN2020-112295 DESCUBRIMIENTO DE NUEVOS MARCADORES DE CANCER EN EL PROTEOMA... 15K€ Cerrado

ODASMIR Origami-DNA/AgNCs Sensor for Detection of miRNAs 181K€ Cerrado

MAT2012-38573-C02-02 UNIVERSAL DIAGNOSTIC PLATFORMS BASED ON OLIGONUCLEOTIDE CODI... 112K€ Cerrado

MAT2017-84959-C2-1-R BIOSENSOR BASADO EN NANOPARTICULAS SUPERPARAMAGNETICAS PARA... 121K€ Cerrado

MAT2011-29335-C03-01 PLATAFORMAS DE DIAGNOSTICO UNIVERSAL BASADA EN NANOPARTICULA... 30K€ Cerrado

MAT2017-87202-P NANODIAGNOSTICO RENTABLE E INTELIGENTE INTEGRADO 61K€ Cerrado

Duración del proyecto: 37 meses Fecha Inicio: 2019-04-15
Fecha Fin: 2022-05-31

Líder del proyecto

UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 185K€

Descripción del proyecto Breast cancer is the most common neoplasm in women and the second leading cause of cancer-related mortality in females worldwide, with 25.1% of incidence and 14.7% of mortality across all cancers. A convenient blood-based tumor marker test has the potential to underpin a significant improvement in early intervention. In this context, this proposal is concerned with development of a new point of care (POC) device for biomarker detection by exploiting a combination of state of the art magnetophoresis, electroanalysis, nanotechnology, and microfluidic integration. In the POC device, dual-functionalized magnetic nanoparticles (dual-NPs) with antibodies and redox probes will be capable of selectively recruiting specific markers from real patient samples and will additionally underpin amplified redox probes for detection. Second, using a magnetic gradient chip, composed of both magnetic gradient (Mag) and microelectrode (Me) arrays, the exerted magnetic gradient field will be capable of separating dual-NPs labeling biomarkers (MBs) from free dual-NPs (MPs) to be positioned at distinct sensing zone of micro-electrode, prior to assay. Herein, only those biomarkers hosted by dual-NPs, will be reported electrochemically for quantification. Three primary objectives are proposed by the candidate: i) development of dual-NPs combining immunological recognition and electrochemical amplification properties, ii) fabrication of Mag chip engineering Mag and Me arrays for magnetic gradient ranking and electrochemical sensing, iii) integration of POC platform with Mag and Me arrays, dual-NPs and microchannels, for cancer biomarker diagnosis. As a proof-of-concept, the developed POC device will be applied to the detection and quantification of breast cancer markers (CA15-3, PAI-1 and HSP90A) in a small (<20µL) blood serum. The detection limit of this device is expected to be ng/ml quantities and duration is estimated to 15 mins for each test with blood serum.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores